Market Cap

Supernus Pharmaceuticals, Inc. Market Capitalization:

$2.84 Billion

USD as of Jan. 1, 2026

business Supernus Pharmaceuticals, Inc. Company Profile

Supernus Pharmaceuticals, Inc. Main Stock Listing

NASDAQ: SUPN

Market Capitalization History of Supernus Pharmaceuticals, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
MERCK Kommanditgesellschaft auf Aktien $62.01 B
Zoetis Inc. $55.81 B
Takeda Pharmaceutical Company Limited $45.42 B
Haleon plc $44.50 B
Teva Pharmaceutical Industries Limited $35.85 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Supernus Pharmaceuticals, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $2.84 B 32.94%
Jan. 1, 2025 $2.13 B 42.38%
Jan. 1, 2024 $1.50 B -28.52%
Jan. 1, 2023 $2.10 B 24.15%
Jan. 1, 2022 $1.69 B 4.97%
Jan. 1, 2021 $1.61 B 28.51%
Jan. 1, 2020 $1.25 B -40.02%
Jan. 1, 2019 $2.09 B -2.36%
Jan. 1, 2018 $2.14 B 44.36%
Jan. 1, 2017 $1.48 B 138.54%
Jan. 1, 2016 $620.7 M 33.41%
Jan. 1, 2015 $465.3 M -13.00%
Jan. 1, 2014 $534.8 M 27.38%
Jan. 1, 2013 $419.8 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Supernus Pharmaceuticals, Inc. Categories

United States languages Healthcare languages Drug Manufacturers—Specialty & Generic
United States Healthcare United States Drug Manufacturers—Specialty & Generic

Stocks & Indices

Supernus Pharmaceuticals, Inc. has the following listings and related stock indices.


Stock: NASDAQ: SUPN

Stock: FSX: S49

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.